Tsumura Past Earnings Performance

Past criteria checks 5/6

Tsumura has been growing earnings at an average annual rate of 7.3%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 5.2% per year. Tsumura's return on equity is 8.4%, and it has net margins of 15.3%.

Key information

7.3%

Earnings growth rate

7.4%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate5.2%
Return on equity8.4%
Net Margin15.3%
Next Earnings Update06 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Tsumura makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:TSMR.F Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24164,61425,20441,0938,288
30 Jun 24157,49923,55549,0470
31 Mar 24150,84516,70740,5118,288
31 Dec 23148,79316,75840,8507,594
30 Sep 23145,23813,59840,8527,594
30 Jun 23142,66214,18240,1797,594
31 Mar 23140,04316,48239,7717,594
31 Dec 22138,24019,32240,0577,313
30 Sep 22136,23720,76038,8967,313
30 Jun 22132,19220,07938,0557,313
31 Mar 22129,54618,83636,7757,313
31 Dec 21129,78317,36539,8796,631
30 Sep 21130,30517,21443,6566,631
30 Jun 21130,88616,67646,5676,631
31 Mar 21130,88315,33248,9176,631
31 Dec 20127,54515,43148,0636,270
30 Sep 20126,44014,81147,4936,270
30 Jun 20124,31713,90746,9806,270
31 Mar 20123,24813,76547,3536,270
31 Dec 19124,08114,55247,5655,926
30 Sep 19123,44014,54847,3595,926
30 Jun 19121,82914,98047,2585,926
31 Mar 19120,90614,59347,0095,926
31 Dec 18118,97813,93346,4826,048
30 Sep 18117,86514,97246,0656,048
30 Jun 18118,58714,82645,7126,048
31 Mar 18117,87914,50445,1766,048
31 Dec 17117,90613,62744,8996,087
30 Sep 17116,87713,79144,0886,087
30 Jun 17115,33012,73043,7586,087
31 Mar 17114,95412,48843,4296,087
31 Dec 16114,02213,07942,4565,968
30 Sep 16114,42411,33042,3295,968
30 Jun 16114,55712,37342,0385,968
31 Mar 16112,62512,55741,7755,968
31 Dec 15111,98612,55042,2676,252
30 Sep 15112,28814,48542,4406,252
30 Jun 15110,57014,20642,6946,252
31 Mar 15110,43814,07542,8356,252
31 Dec 14112,44515,40742,5365,949
30 Sep 14109,36917,10942,4995,949
30 Jun 14110,18717,24842,6165,949
31 Mar 14110,05718,05042,8595,949
31 Dec 13107,82118,02343,7564,904

Quality Earnings: TSMR.F has high quality earnings.

Growing Profit Margin: TSMR.F's current net profit margins (15.3%) are higher than last year (9.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: TSMR.F's earnings have grown by 7.3% per year over the past 5 years.

Accelerating Growth: TSMR.F's earnings growth over the past year (85.4%) exceeds its 5-year average (7.3% per year).

Earnings vs Industry: TSMR.F earnings growth over the past year (85.4%) exceeded the Pharmaceuticals industry 54.6%.


Return on Equity

High ROE: TSMR.F's Return on Equity (8.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 12:16
End of Day Share Price 2024/09/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tsumura & Co. is covered by 18 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCompany Forecast
Fumiyoshi SakaiCredit Suisse
Kazuaki HashiguchiDaiwa Securities Co. Ltd.